FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Zydus Pharmaceuticals (USA) Entecavir Tablets Recall

Entecavir Tablets, USP, 0

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Sep 24, 2025
Recall ID
D-0656-2025
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled Entecavir Tablets starting Sep 4, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0656-2025 on Sep 24, 2025. Reason: Failed Impurity/Degradation Specifications. Status: Ongoing.

Why it was recalled

Failed Impurity/Degradation Specifications

Product description

Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Lot numbers, UPCs & expiration codes

Lot E309376; Exp 11/30/2025

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0656-2025
Classification
Class II
Status
Ongoing
Recall initiated
Sep 4, 2025
FDA report date
Sep 24, 2025
Quantity
4344 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0656-2025, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Ongoing
Country
United States
Event ID
97556
Address
73 Route 31 N
Code information
Lot E309376; Exp 11/30/2025
Postal code
08534-3601
Report date
Sep 24, 2025
Product type
Drugs
Recall number
D-0656-2025
Classification
Class II
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
4344 bottles
Reason for recall
Failed Impurity/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.
Distribution pattern
U.S. Nationwide
Recall initiation date
Sep 4, 2025
Center classification date
Sep 18, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0656-2025, published Sep 24, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls